期刊簡介 | |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | Annals of Thoracic Medicine LetPub Score 4.8
50 ratings
Rate
Reputation 5.8 Influence 3.6 Speed 7.0 | ||||||||||||||||||||||||
期刊簡稱 | ANN THORAC MED | ||||||||||||||||||||||||
ISSN | 1817-1737 | ||||||||||||||||||||||||
E-ISSN | 1998-3557 | ||||||||||||||||||||||||
h-index | 29 | ||||||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||||||
自引率 (2023-2024) | 0.00%自引率趨勢 | ||||||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||||||
官方網站 | http://www.thoracicmedicine.org/backissues.asp | ||||||||||||||||||||||||
在線稿件提交 | |||||||||||||||||||||||||
開放訪問 | Yes | ||||||||||||||||||||||||
出版商 | Wolters Kluwer Medknow Publications | ||||||||||||||||||||||||
主題領域 | CARDIAC & CARDIOVASCULAR SYSTEMS | ||||||||||||||||||||||||
出版國/地區 | INDIA | ||||||||||||||||||||||||
發行頻率 | 四半期刊行 | ||||||||||||||||||||||||
創刊年 | 2006 | ||||||||||||||||||||||||
每年文章數 | 29每年文章數趨勢 | ||||||||||||||||||||||||
黃金OA百分比 | 94.79% | ||||||||||||||||||||||||
OA Related Info | APC: Yes( INR24000; ) APC waiver:No Other charges: No Keywords: pulmonology、cardiology、thoracic surgery、transplantation、sleep and breathing、airway diseases Useful LinksAims & ScopeAuthor InstructionsEditorial BoardDouble anonymous peer review | ||||||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q3
| ||||||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1817-1737%5BISSN%5D | ||||||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: >12 Week(s), or Invited contributions | ||||||||||||||||||||||||
競爭力 * | 來自作者的數據: Easy | ||||||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 下一頁 末頁 (頁 | |
[Annals of Thoracic Medicine] 的評論 | 撰寫評論 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 21:31:30 評論於 Just accept the editor's modification suggestions if you agree. If you disagree, please write down your reasons below the comments and provide feedback to the editor. If both parties disagree, then negotiate(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 20:08:53 評論於 When replying to reviewers' comments, all questions must be answered one by one without omission; try to meet the experimental requirements in the comments, and if unable to meet, provide a reasonable explanation why it cannot be done; the literature recommended by the reviewers must be cited and thoroughly discussed; when submitting a revised manuscript, make sure to check the corrections made in the original manuscript. If you agree with the editor's proposed modifications when replying to the editorial comments, simply accept the changes. If you disagree, write down your reasons below the comments and send the feedback back to the editor. If there is a disagreement, negotiate further(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 魂魄彦露 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-28 15:59:40 評論於 What is the difference between responding to reviewers' comments and responding to the journal editor's comments?(0) 讚! | 魂魄彦露 |
作者: 破戒阳平 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-27 11:06:11 評論於 How to respond to journal editor's comments?(0) 讚! | 破戒阳平 |
作者: 六合春姝 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-03-26 16:24:39 評論於 How long is the review period for this magazine?(0) 讚! | 六合春姝 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-07-14 08:58:49 評論於 From below 1.5 points, now nearing 2 points, is a good sign, this magazine is worth owning(0) 讚! | 凌霄高洁 |
首頁 上一頁 1 下一頁 末頁 (頁 |
Contact us